Eli Lilly Weight Loss Medication - Search News

News

Eli Lilly sales soar 45% on weight loss drug demand

CNBC on MSN · 1d

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.

Reuters on MSN · 1d

Eli Lilly's weight-loss drug sales miss expectations, shares fall

Eli Lilly on Thursday posted better-than-expected quarterly results, although sales of its popular weight-loss drug, Zepbound, came in slightly below Wall Street estimates, sending its shares down 4% in premarket trading.

The Associated Press on MSN · 18h

Lilly’s star weight-loss drug Zepbound faces coverage challenge from CVS Health

CVS Health will drop the weight-loss drug Zepbound from its insured pharmacy options this summer. Employers and insurers may follow suit.

13don MSN

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

16hon MSN

Exclusive: WHO to back use of weight-loss drugs for adults globally, raises cost issue

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

13h

Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade'

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results